Insider Transactions Reported by 16 Insiders of HALOZYME THERAPEUTICS, INC.

Symbol
HALO on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

HALOZYME THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Helen Torley PRESIDENT AND CEO, Director $55,979,643 -$24,456,412 -30% 09 Dec 2025
Michael J. LaBarre Svp, Chief Technical Officer $11,633,809 -$1,260,681 -9.8% 25 Feb 2025
CONNIE MATSUI Director $9,870,372 29 Nov 2024
Matthew L. Posard Director $4,458,628 01 May 2025
Mark Howard Snyder Svp, Chief Legal Officer $3,618,709 12 Jun 2025
Nicole LaBrosse Svp, Chief Financial Officer $3,600,199 -$1,687,852 -32% 22 Sep 2025
Bernadette Connaughton Director $3,016,006 -$641,534 -18% 01 Dec 2025
JEAN-PIERRE BIZZARI Director $2,563,056 05 May 2023
Jeffrey William Henderson Director $1,973,770 -$878,659 -31% 01 May 2025
Akiko Moni Miyashita Director $1,501,706 01 May 2025
Barbara Gayle Duncan Director $1,199,522 01 May 2025
Masaru Matsuda SVP, General Counsel $999,796 04 Sep 2021
Cortney Caudill Svp, Chief Operating Officer $830,325 -$277,905 -25% 01 Nov 2025
James M. Daly Director $738,108 11 Aug 2023
Mahesh Krishnan Director $642,306 01 May 2025
James Paul Lang Director 04 Dec 2025

Recent Insider Transactions by Companies or Individuals for HALOZYME THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.